- Diabetes mellitus and insulin resistance, dyslipidemia, hypertension, gout2013 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Antihypertensive and hypolipidemic drug in one tablet2008 | First Faculty of Medicine
- Princples of treatment to patients with metabolic syndrome2008 | First Faculty of Medicine
- Metabolic syndrome2010 | First Faculty of Medicine
- Metabolic syndrome and sexual health couple2013 | First Faculty of Medicine
- How to create cooperative patient for antihypertensive and hypolipidemic therapy2017 | Second Faculty of Medicine
- Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A pilot study2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Why dyslipidemia and hypertension is still not an endangered species risk factors2016 | Second Faculty of Medicine
- Early and long-term restraining of dyslipidaemia and hypertension - how to be a person with risks, not a "patient" during your life2019 | Second Faculty of Medicine
- Incidence of metabolic syndrome (MS) in patients in ATLET project2009 | First Faculty of Medicine
- Once a few words to study VATARO2016 | First Faculty of Medicine
- An effective communication between the physician and the patient in an early intervention of hypertension and dyslipidemia2021 | Faculty of Medicine in Pilsen
- Early cardiovascular risk intervention means cummulation of positive impacts in time2021 | First Faculty of Medicine
- Hypertension and dyslipidemia2010 | Faculty of Medicine in Hradec Králové
- Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach2019 | First Faculty of Medicine, Second Faculty of Medicine
- Residual risk of cardiovascular incidents2009 | First Faculty of Medicine
- Residual risk: a new target of cardiovascular prevention2009 | First Faculty of Medicine
- Prospective, multicentric, non-interventional study to assess the existing treatment of type 2 diabetes mellitus patients inadequately controlled with metformin monotherapy - KOMETA CZ2013 | First Faculty of Medicine
- Importance of fixed-dose combinations in cardiovascular prevention: the possibility of treating two diagnoses with a single pill2019 | First Faculty of Medicine
- Cardiovascular prevention in menopause2009 | First Faculty of Medicine
- A strategy for cardiovascular prevention: that's what matters!2019 | First Faculty of Medicine
- Cardiovascular risks in neurology2023 | First Faculty of Medicine
- Diabetes mellitus and cardiovascular disease2013 | Faculty of Medicine in Pilsen
- Early and comprehensive cardiovascular prevention in a general practitioner's office. Dyslipidemia and hypertension: The two most common risk factors and the possibility of their EARLY control2020 | Second Faculty of Medicine
- Dyslipidemia and hypertension: The two most common risk factors and the possibility of their early contro2020 | Second Faculty of Medicine
- Vascular age2019 | First Faculty of Medicine
- Prevention of atherosclerosis2010 | First Faculty of Medicine
- Genetic Analysis of Cardiovascular Risk Factor Clustering in in Spontaneous Hypertension2000 | First Faculty of Medicine
- Metabolic comorbidities during pregnancy and diabetes2013 | First Faculty of Medicine
- Lipid-lowering treatment in metabolic syndrome2009 | First Faculty of Medicine